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summary 
Ten women with DSM-III-defined panic attacks (five with and five without agoraphobia) had symptom 
severity rated daily. weekly. and retrospectively through one full menstrual cycle. Substantial fluctuations 
in retrospective ratings of severity were observed. with the premenstrual week being rated as most scvcrc. 
Daily and weekly ratings showed much smaller fluctuations in the predicted direction. Possible reasons for 
this outcome are considered. 
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Introduction 
Many women report both physical and psycho- 
logical symptoms associated with the pre- 
menstruum. as acknowledged by the terms ‘pre- 
menstrual tension or syndrome’ (e.g., Frank, 1931; 
Dalton, 1964; Steiner et al., 1980: Rubinow and 
Roy-Byrne, 1984) or ‘late luteal phase dysphonc 
disorder’ (American Psychiatric Association. 1987). 
Among the psychologrcal symptoms in otherwise 
normal women reported to be greater premenstru- 
ally is anxiety (e.g., Golub. 1976; Veith et al.. 
1984). although others have not observed a reli- 
able premenstrual increase in anxiety (cg.. 
Lahmeyer et al., 1982; Van Den Akker and Step- 
toe. 1985). Retrospective studies of women with 
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anxiety disorders have also reported a premenstru- 
al exacerbation of anxiety symptoms (Breicr et al.. 
1986; Cameron et al.. 1986). The purpose of the 
present study was to evaluate prospectively 
menstruating women with the anxiety disorder, 
panic attacks with or without agoraphobia 
(American Psychiatric Association 1980. 1987). in 
order to determine if the retrospective reports of 




Ten menstruating women who presented con- 
secutively to the University of Michigan Anxiety 
Disorders Program were studied. All were 
evaluated by an experienced clinician, using both 
the Structured Interview for DSM-III (Spitrer and 
Williams, 1983) and a semi-structured clinical in- 
terview. By coincidence. five reached dragnostic 
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criteria for panic disorder, as defined by DSM-III. 
and five reached criteria for agoraphobia with 
panic attacks. Age of the subjects. mean age of 
onset of the disorder, and menstrual cycle length 
(days) for the cycle studied were recorded. No 
subject reached criteria for any other DSM-III or 
DSM-III-R Axis I disorder at the time of study, 
all reported being medically in good health. and 
all were drug-free for at least 1 week before and 
throughout the study: tight had rccciwd prior 
drug treatment. 
,411 subjects were studied for at least one full 
menstrual cycle from day of menstrual onset to 
day prior to day of onset of the next menstrual 
period. For each subject. the study was started at 
the tirnc of cnrollmcnt. irrcspectivc of the point in 
the cycle, but continued at least until completion 
of one full cycle (day of onset to last day of that 
cycle); thus, data were always available for one 
full cycle. Subjects were told that the purpose of 
the study was to evaluate the longitudinal course 
of their symptoms; no mention wab made of any 
intcrcst in the relationship of symptoms to the 
menstrual cycle. However. among many data items 
collected. day of onset of menstrual flow was 
determined for each subject so that coincidence of 
symptoms and cycle could be determined. At the 
end of each day during the study. each subject 
recorded separately the number of (a) full unex- 
pccted. (b) full situational. (c) lirnitcd uncxpcctcd. 
and (d) limited situational panic attacks (Ameri- 
can Psychiatric Association. 1987). Each attack 
was also rated for duration (in minutes) and sever- 
ity (O-9). Additionally, the severity (O-9) for all 
criterion symptoms listed in DSM-III-K for all 
panic attacks on that day were recorded. Finally, a 
list of 25 sy-mptoms associated with panic, gener- 
ahzed anxiety disorder. and/or ‘late luteal phase 
dysphoric disorder’, as defined in DSM-III-R, were 
also rated (O-9). For all ‘O-9’ ratings, 0 =‘none’. 
and 9 = ‘most ever’. 
In addition to the daily rating, patients were 
seen every week by the same clinician; further 
self-ratings and clinician rating scales were com- 
pleted at these times. These included: (a) the same 
ratings of the four ty-pes of panic attacks as dc- 
scribed above. done jointly by clinician and pa- 
tients with the average intensity of all attacks 
(O-9): (h) the percentage of time spent feeling 
anxious br/rrve~t o//ackv: (c) the same 25 symp- 
tom< as rated daily by the patients: (d) the Shee- 
han (1986) and Hamilton (1959) anxiety scales, 
and the SCL-90-R (Derogatis, 1983) (all rated 
0 ~ none to 4 = severe); (e) the Sheehan disability 
scale (Sheehan. 1986): ( f) and the Marks-Sheehan 
fear (O-9) and avoidance (0 4) scales (Marks and 
Mathews, 1979: Shechan, 1986). 
After completion of the daily and weekly rat- 
ings. before description of the purpose of the 
study. all patients rated, retrospectively for each 
week, the average severity (O-9) of pamc attacks. 
agoraphobic symptoms. and ‘premenstrual symp- 
toms’. Additionally. the same 25 symptoms were 
rated again. After completion of the retrospective 
ratings, patients were ‘debriefed’ concerning their 
understanding of 111~ purpobc of the study. and 
their ‘thoughts on any possible reasons for the 
outcome. 
Statistical tests used included the Sign test, 
paired (-tests, and profile analyses: profile analy- 
sis is a multivariate statistical test analogous to 
repeated measures ANOVA with one hetween- 
group and one within-group variable (Harris, 
1975). All significance tests were performed at 
P ( 0.05; no adjustment for number of tests was 
uwl. Because the durations of the menstrual cycles 
studied were not the same for each subject and 
often did not equal 2X days, data analysis for the 
prospective ratings actually involved 21 days. 
These were the seven consecutive days starting 
with the first day of the menstrual period (peri- 
menstrual), the scvcn days immcdiatcly prcccding 
the perimenstrual time (premenstrual). and the 
seven days closest to mid-cycle. Scores are re- 
ported (Table I) as means of these 7.day periods. 
Shorter periods were also used for some of these 
prospective calculations; conclusions did not dif- 
fei-. 
Results 
Age of the subjects was 34.3 i 7.1 years (mean 
k standard deviation), and age of onset of the 
disorder was 22.6 i 4.X years. The mean menstrual 
cyc le  l e n g t h  was  30.1 _+ 6.7 days ,  w h i c h  is n o r m a l  
( W o r l d  H e a l t h  O r g a n i z a t i o n ,  1983) .  F o u r  h a d  b e e n  
d i a g n o s e d  p r e v i o u s l y  as h a v i n g  ' p r e m e n s t r u a l  syn-  
d r o m e ' .  Six we re  m a r r i e d ,  t h r e e  d i v o r c e d ,  a n d  o n e  
n e v e r  m a r r i e d .  A c r o s s  t h e  m e n s t r u a l  cyc le  a v e r a g e  
n u m b e r s  of  p a n i c  a t t a c k s  p e r  w e e k  were :  1.60 ful l  
u n e x p e c t e d ;  0.73 l i m i t e d  u n e x p e c t e d ;  1.20 ful l  
s i t u a t i o n a l ;  a n d  2.97 l i m i t e d  s i t u a t i o n a l .  
Severa l  i n d i v i d u a l  s y m p t o m s  s h o w e d  s i g n i f i c a n t  
f l u c t u a t i o n s  ac ross  t he  m e n s t r u a l  cyc le  w h e n  r a t e d  
r e t r o s p e c t i v e l y ;  t h e y  we re  ' d e p r e s s e d '  ( P  < 0.008) ,  
' c h a n g e  of  a p p e t i t e '  ( P  < 0.02),  ' m o o d i n e s s '  ( P  < 
0 .003) ,  ' l o s s  of  i n t e r e s t '  ( P  < 0.05),  ' f e e l i n g  k e y e d  
u p '  ( P  < 0.02),  ' i r r i t a b i l i t y '  ( P  < 0.03),  a n d  ' p h y s i -  
ca l  d i s c o m f o r t '  ( P  < 0 .007)  ( T a b l e  1). Al l  of  t h e s e  
s y m p t o m s  s h o w e d  h i g h e s t  scores  d u r i n g  the  p re -  
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m e n s t r u a l  a n d / o r  p e r i m e n s t r u a l  weeks .  In  c o n -  
t r a s t  to  t h e s e  r e t r o s p e c t i v e  r a t i ngs ,  a m o n g  t h e s e  25 
s y m p t o m s ,  o n l y  ' l o s s  o f  i n t e r e s t '  s h o w e d  a s igni f i -  
c a n t  f l u c t u a t i o n  d u r i n g  t he  week ly  r a t i n g s  ( P  < 
0.02),  a n d  o n l y  ' p h y s i c a l  d i s t r e s s '  ( P  < 0.04)  a n d  
' m u s c l e  t e n s i o n '  ( P  < 0 . 0 4 )  s h o w e d  s i g n i f i c a n t  
f l u c t u a t i o n s  in  t he  p r o s p e c t i v e  r a t ings .  A d d i t i o n -  
ally,  t he  m e a n  score  for  t he  25 s y m p t o m s  s h o w e d  
a s i g n i f i c a n t  f l u c t u a t i o n  fo r  the  r e t r o s p e c t i v e  ( P  < 
0 .03)  b u t  n o t  fo r  t he  w e e k l y  o r  p r o s p e c t i v e  r a t -  
ings ;  th i s  was  d u e  p r i m a r i l y  to  h i g h e r  r e t r o s p e c t i v e  
m e a n  scores  in  t he  p r e / p e r i m e n s t r u u m .  In  c o n -  
t ras t ,  t h e r e  was  a s i g n i f i c a n t l y  l a rge r  number of  
s y m p t o m s  t h a t  w e r e  g r e a t e r  p r e m e n s t r u a l l y  t h a n  
in  t he  m i d - c y c l e  w e e k s  ( 2 0 / 2 5 ,  b y  the  S ign  test ,  
P < 0.005) .  T h u s ,  b a s e d  o n  t he  s a m e  set of  sy rup-  
TABLE 1 
AVERAGE SCORES OF ALL TEN SUBJECTS ON RETROSPECTIVELY, WEEKLY, AND PROSPECTIVELY RATED 
SYMPTOMS 
Retrospective Weekly Prospective 
t 2 3 4 1 2 3 4 1 2 3,4 
Trembling 5.70 4.80 3.60 3.70 4.30 3.70 3.30 4.40 2.67 2.51 2.16 
Muscles tense 6.90 5.90 2.00 2.10 4.20 3.90 2.90 2.90 3.00 3.44 2.47 
Restless 5.20 2.70 2.30 2.50 3.50 3.50 3.70 3.50 2.37 2.59 2.61 
Low energy 5.40 3.70 1.30 1.80 3.50 3.90 3.00 2.50 2.59 2.74 1.73 
Depressed 7.10 4.90 2.30 2.80 4.10 4.50 3.20 3.20 2.51 2.67 2.21 
Change of appetite 6.50 1.70 0.80 1.30 3.20 1.40 1.60 2.80 1.66 0,91 1.21 
Worry 4.80 3.20 2.20 2.40 3.20 3.10 2.70 2.70 1.04 1.40 1.40 
Moodiness 7.90 5.20 2.20 2.70 4.00 3.60 3.20 3.30 2.36 2.26 1.57 
Lost interest 3.90 2.20 1.10 1.20 3.20 3.60 1.20 2.30 1.61 1.14 1.21 
Trouble sleeping 2.70 3.10 1.80 1.80 3.80 3.10 2.50 3.00 1.99 1 ~31 1.21 
Increased sleeping 1.40 0.70 0.00 0.10 0.70 0.00 0.40 0.90 0.41 0.20 0.29 
Shortness of breath 4.80 3.50 2.80 2.80 3.60 2.70 4.00 4.10 2.00 1.87 2.00 
Palpitations 5.00 4.60 2.60 3.60 3.70 3.20 3.50 3.70 2.63 2.29 2.17 
Sweating 2.60 2.80 1.10 1.10 0.80 2.20 1.00 0.90 1.23 1.44 1.10 
Dry mouth 1.60 1.80 1.80 1.60 1.40 1.60 0.70 1.10 1.00 0.91 0.79 
Dizziness 4.10 4.00 2.30 2.70 2.80 2.10 1.70 2.40 1.24 1.41 1.41 
Nausea 2.50 2.80 1.50 1.40 2.20 2,10 2.10 2.80 1.56 1.60 1.58 
Hot flashes 2.70 3.10 1.80 1.80 1.70 3.40 2.20 1.90 1.44 1.54 1.37 
Increased urination 1.90 1.60 0.60 0.60 1.70 2.80 2.90 2.00 0.34 0.90 0.21 
Trouble swallowing 0.70 0.70 0.70 0.70 0.70 1.40 0.70 1.40 1.00 0.74 0.90 
Keyed up 6.50 5.00 2.90 2.80 5.30 4.40 4.40 5.32 2.76 2.64 2.54 
Jumpy 4.90 4.40 2.50 2.10 1.70 3.70 2.10 2.50 2.09 1.47 1.40 
Difficulty concentrating 3.90 3.90 2.70 2.60 2.80 3.80 3.20 2.90 1.60 1.14 1.37 
Irritability 7.90 5.90 3.30 3.10 3.70 4.00 3.40 4.50 2.83 1.97 1.57 
Physical discomfort 7.50 5.20 1.30 1.90 5.20 5.30 4.10 4.40 2.64 3.09 1.81 
Mean Score 4.56 3.50 1.94 2.05 3.00 3.08 2.55 2.86 1.86 1.78 1.52 
All scores rated 0 ( = ' n o n e ' )  to 9 ( = 'most ever'); 1 = premenstrual week: 2 - perimenstrual week; and 3 and 4 mid-cycle weeks (the 
seven days closest to the mid-cycle point for the prospective data: "3,4'). 
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toms, rated on the same scale (0 9), retrospective 
patient ratings indicated greater symptom fluctua- 
tion across the menstrual cycle than either daily 
prospective patient ratings or weekly joint pa- 
tient-clinician ratings, but the number of symp- 
toms that showed at least a small increase pre- 
menstrually was significant. 
In addition to the 25 symptoms described above 
(Table 1), other retrospective ratings were signifi- 
cant. Patients rated 'panic  attacks' ( P < 0 . 0 3 ) ,  
'agoraphobic  symptoms'  (P  < 0.006), and 'pre-  
menstrual symptoms '  ( P < 0 . 0 0 1 )  all as signifi- 
cantly fluctuating over the cycle, again with the 
premenstrual /per imenstrual  time as highest. Fur- 
ther, nine of the ten subjects retrospectively rated 
their peak panic and ' tension'  severity as having 
occurred during the premenstrual week. Among 
the weekly ratings, only intensity of full situa- 
tional panic attacks fluctuated significantly (P  < 
0.02). No other prospective ratings fluctuated sig- 
nificantly, and patients rated themselves prospec- 
tively as under equal levels of 'stress'  across the 
menstrual cycle. 
Mean scores for patients diagnosed as having 
agoraphobia as well as panic attacks were higher 
on most items than for patients with panic attacks 
only. Sometimes this difference reached statistical 
significance (e.g., mean score for all SCL-90-R 
items, P < 0.002), and sometimes it did not. Over- 
all, it appeared that patients with agoraphobia 
were more severely affected than those without. 
Only one subject, during the post-study 'de- 
briefing', indicated that she thought the purpose 
of the study was to study menstrual changes in 
anxiety symptoms. Eight of the ten subjects 
thought that the month of the study was a symp- 
tomatically typical month; one stated that her 
symptoms were more severe and another stated 
that they were less severe. 
Discussion 
The results of this study agree with prior stud- 
ies which indicated that women with panic at- 
tacks, with or without agoraphobia, believe their 
anxiety disorder is more severe pre- a n d / o r  peri- 
menstrually. However, daily ratings of the identi- 
cal symptoms, as well as other anxiety ratings, 
indicate that fluctuations in anxiety symptoms are 
actually rather small across the menstrual cycle. 
The discrepancy in results of the two types of 
ratings is mainly, but not completely, due to higher 
ratings retrospectively than prospectively in the 
pre- and perimenstrual portions of the menstrual 
cycle. Weekly ratings showed intermediate sever- 
ity, but minimal menstrual fluctuation, despite the 
fact that the clinician was not blind to the study 
hypothesis or to the point in the cycle at which the 
rating was being performed. Post-study 'debrief- 
ings' indicated that only one of the patients sus- 
pected the specific purpose of the study. 
Only ten subjects were evaluated in the study; 
if more subjects or more cycles had been studied, 
or if patients had been more severely anxious, the 
actual differences observed in several symptoms 
across the cycle might have reached statistical 
significance (Table 1). Even if this were to occur, 
however, it seems likely that the discrepancy be- 
tween retrospective and prospective daily ratings 
in magnitude of effect would remain. Fluctuations 
of subjective 'stress '  did not appear to play any 
role in outcome. 
There are several possible explanations for the 
observed results. (a) Were patients more agora- 
phobic pre/per imenstrual ly ,  and did a reduction 
of daily activity lead to lower daily symptom 
ratings? Subjects denied this during the debrief- 
ing: furthermore, only half of the subjects had 
agoraphobia of clinically significant severity. (b) 
Did patients subjectively decrease their prospecti~,e 
symptom ratings in the pre /per imens t ruum be- 
cause they 'expected'  them to be higher? Again, 
results of debriefings indicated that this was not 
the case. (c) Were the retrospective pre /per i -  
menstrual ratings increased due to saliency (i.e., 
were the retrospective ratings done just after 
menstrual onset, at the end of the rated cycle)? 
No, retrospective ratings and debriefings were 
done at variable intervals after completion of the 
prospective daily ratings. 
In contrast to the possible explanations listed 
above, which do not appear to account for the 
observed results, two others explanations seem 
more likely. First, it is possible that the symptoms 
only show minimal variation (as indicated by the 
prospective ratings), but that these women have 
learned from sources other than their own subjec- 
tive experience to expect more or more severe 
symptoms in the p remens t ruum;  thus, in the retro- 
spective ratings, which are temporal ly more re- 
moved from the actual experience than are the 
prospective daily ratings, subjects recall their 
symptoms as more severe at that point  in the 
menstrual  cycle. In  other words, there is little 
actual f luctuat ion in symptomatology,  bu t  only an 
exaggeration due to an error of memory based on 
inappropr ia te  expectation. 
The second explanat ion  is that pat ients  are 
experiencing some non-specific ' a rousa l '  in the 
p r e / p e r i m e n s t r u u m ,  and that this arousal is dif- 
ferent enough from the actual anxiety symptoms 
that it does not  influence the daily ratings, but  it is 
nevertheless salient enough to be recalled and  to 
be mislabeled or misat t r ibuted to an exacerbation 
of anxiety symptomatology at the temporal ly re- 
mote point  of retrospective ratings. Several studies 
have suggested that au tonomic  arousal does change 
across the menstrual  cycle (Wineman,  1971; Little 
and  Zahn,  1974; Collins et al., 1985; Asso, 1986). 
Perhaps consistent  with this possibili ty is the fact 
that the symptoms which f luctuated the most, as 
rated either retrospectively or prospectively, were 
not  necessarily the symptoms most specific to 
panic, but  were an apparent ly  non-specific mix- 
ture of symptoms involving anxiety, irritability, 
affect change, appetite change, physical discom- 
fort, etc. (Table 1). 
It would be premature  to conclude that the 
menst rual  cycle does not  affect pathological 
anxiety. Many  women ( including most of the par- 
t icipants of this study) insist that they are more 
symptomat ic  pre- and perimenstrual ly.  Some even 
claim to need more medicat ion at that time. And 
some fluctuation,  albeit small, did appear to oc- 
cur. Nevertheless, these results suggest that recall 
of any f luctuat ion which does occur is substan-  
tially augmented in memory  days to weeks later. 
Furthermore,  prior research as well as the results 
of this study suggest that any symptom fluctuat ion 
which does occur might not  be of specific anxiety 
symptoms per se but  rather of mood-related or 
other less specific symptoms such as ' i r r i tabi l i ty ' .  
In  this vein, a s tudy of women present ing to a 
clinic identified as a 'P remens t rua l  Syndrome 
Clinic '  found not  only an increase in the n u m b e r  
of women expected to have a pr imary anxiety 
disorder bu t  also an increase in the n u m b e r  of 
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women with an affective disorder or substance 
abuse (Stout et al., 1986). More research is needed, 
especially concern ing  the possibili ty that women 
with pr imary anxiety disorders might be especially 
prone  to mens t rua l  f luctuat ion of non-specific 
arousal, since other research has already dem- 
onstrated au tonomic  abnormal i t ies  in people with 
anxiety disorders (Cameron  and Nesse, in press). 
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